Dr. Ara A. Ajemian, MD

Dr. Ajemian practices at Valley Physician Services in Paramus, New Jersey.

Dr. Ajemian's NPI, 1154359727, was assigned on June 30, 2006. Dr. Ajemian graduated from American University of Beirut Faculty of Medicine in 1994. Dr. Ajemian holds New Jersey license 25MA07981900.

Dr. Ajemian's primary practice is Valley Physician Services, at 15 Essex Rd, Paramus, NJ 07652 in Bergen County. The practice phone is (201) 291-6086.

Dr. Ajemian's primary practice is Valley Physician Services in Paramus, New Jersey. Dr. Ajemian is also affiliated with The Valley Hospital. The medical group on file is Valley Medical Group. Dmand AI also links Dr. Ajemian to 1 more hospital, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ajemian practices, 4 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Ajemian's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Ajemian is board certified in family medicine by the American Board of Family Medicine. Dr. Ajemian is licensed in New Jersey.

CMS data shows 2,120 Medicare services from Dr. Ajemian across 18 procedure codes in 2024, for 526 Medicare patients. Medicare paid $130,081 for them. Every service was in an office.

CMS counts 526 Medicare patients who saw Dr. Ajemian in 2024. The largest group is 65 to 74, with 259 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ajemian's median patient age at 65, with 46% women.

In 2024, Dr. Ajemian wrote 4,721 Medicare Part D claims for 569 patients. 89% of them were for generic drugs. CMS names the drug for 4,174 of them, across 84 drugs with 11 or more claims each, at $312,773 in total drug cost. In 2023, CMS named 3,899 claims across 77 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Ajemian for performance year 2024, reported through an alternative payment model (APM). Dr. Ajemian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ajemian as offering telehealth.

CMS Open Payments shows 177 general payments to Dr. Ajemian from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. AstraZeneca Pharmaceuticals LP paid the most, $583.

Dr. Ajemian graduated from American University of Beirut Faculty of Medicine in 1994.